drugset / Trial / NCT05416957
Food Effect Bioavailability Study of Vortioxetine Hemihydrobromide Orally Disintegrating Tablets
RandomizedCrossoverOpen-labelTreatment
Summary
An open label, randomized, two-period, two-treatment \[Treatment A (Investigational product administration under fasting condition) vs Treatment B (Investigational product administration under fed condition)\], two-sequence, crossover, balanced, single dose oral food effect bioavailability study.
Timeline
- Start
- 2022-09-18
- Primary completion
- 2022-10-27
- Completion
- 2022-10-27
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Vortioxetine | Unknown | 20 mg | Oral |